The Immunogenetics of Psoriasis and Implications for Drug Repositioning.

Abstract excerpt

Psoriasis is a genetically-regulated, T lymphocyte-mediated autoimmune skin disease that causes systemic damage, seriously affecting patient quality of life and survival. Psoriasis treatments, which aim to control the disease's development, are greatly limited because its etiology and pathogenesis have not yet been fully elucidated. A large number of studies have demonstrated that immunogenetic elements are the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmune Diseases
• Share to Drug Repositioning
• Share to Genetic Predisposition to Disease